nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Myocardial ischaemia—Fluorouracil—skin cancer	0.00807	0.00807	CcSEcCtD
Iohexol—Nervous system disorder—Vismodegib—skin cancer	0.0078	0.0078	CcSEcCtD
Iohexol—Skin disorder—Vismodegib—skin cancer	0.00772	0.00772	CcSEcCtD
Iohexol—Extravasation—Fluorouracil—skin cancer	0.00743	0.00743	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00724	0.00724	CcSEcCtD
Iohexol—Gastrointestinal disorder—Vismodegib—skin cancer	0.00686	0.00686	CcSEcCtD
Iohexol—Pain—Vismodegib—skin cancer	0.0068	0.0068	CcSEcCtD
Iohexol—Gastrointestinal pain—Vismodegib—skin cancer	0.0065	0.0065	CcSEcCtD
Iohexol—Eye disorder—Vemurafenib—skin cancer	0.00646	0.00646	CcSEcCtD
Iohexol—Cardiac disorder—Vemurafenib—skin cancer	0.00642	0.00642	CcSEcCtD
Iohexol—Abdominal pain—Vismodegib—skin cancer	0.00629	0.00629	CcSEcCtD
Iohexol—Angiopathy—Vemurafenib—skin cancer	0.00627	0.00627	CcSEcCtD
Iohexol—Mediastinal disorder—Vemurafenib—skin cancer	0.00623	0.00623	CcSEcCtD
Iohexol—Arthritis—Bleomycin—skin cancer	0.00623	0.00623	CcSEcCtD
Iohexol—Photophobia—Fluorouracil—skin cancer	0.00609	0.00609	CcSEcCtD
Iohexol—Erythema—Vemurafenib—skin cancer	0.00602	0.00602	CcSEcCtD
Iohexol—Thrombophlebitis—Temozolomide—skin cancer	0.0059	0.0059	CcSEcCtD
Iohexol—Dysgeusia—Vemurafenib—skin cancer	0.00589	0.00589	CcSEcCtD
Iohexol—Urinary tract disorder—Imiquimod—skin cancer	0.00582	0.00582	CcSEcCtD
Iohexol—Myocardial ischaemia—Docetaxel—skin cancer	0.00582	0.00582	CcSEcCtD
Iohexol—Urethral disorder—Imiquimod—skin cancer	0.00578	0.00578	CcSEcCtD
Iohexol—Pruritus—Vismodegib—skin cancer	0.00563	0.00563	CcSEcCtD
Iohexol—Eye disorder—Imiquimod—skin cancer	0.00551	0.00551	CcSEcCtD
Iohexol—Flushing—Imiquimod—skin cancer	0.00547	0.00547	CcSEcCtD
Iohexol—Diarrhoea—Vismodegib—skin cancer	0.00544	0.00544	CcSEcCtD
Iohexol—Thrombophlebitis—Fluorouracil—skin cancer	0.00544	0.00544	CcSEcCtD
Iohexol—Extravasation—Docetaxel—skin cancer	0.00536	0.00536	CcSEcCtD
Iohexol—Angiopathy—Imiquimod—skin cancer	0.00535	0.00535	CcSEcCtD
Iohexol—Swelling—Fluorouracil—skin cancer	0.00533	0.00533	CcSEcCtD
Iohexol—Immune system disorder—Imiquimod—skin cancer	0.00533	0.00533	CcSEcCtD
Iohexol—Mediastinal disorder—Imiquimod—skin cancer	0.00531	0.00531	CcSEcCtD
Iohexol—Arrhythmia—Imiquimod—skin cancer	0.00527	0.00527	CcSEcCtD
Iohexol—Cough—Vemurafenib—skin cancer	0.00525	0.00525	CcSEcCtD
Iohexol—Bone disorder—Docetaxel—skin cancer	0.00518	0.00518	CcSEcCtD
Iohexol—Mental disorder—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Iohexol—Bronchospasm—Bleomycin—skin cancer	0.00515	0.00515	CcSEcCtD
Iohexol—Erythema—Imiquimod—skin cancer	0.00513	0.00513	CcSEcCtD
Iohexol—Arthralgia—Vemurafenib—skin cancer	0.00512	0.00512	CcSEcCtD
Iohexol—Vomiting—Vismodegib—skin cancer	0.00506	0.00506	CcSEcCtD
Iohexol—Rash—Vismodegib—skin cancer	0.00501	0.00501	CcSEcCtD
Iohexol—Dermatitis—Vismodegib—skin cancer	0.00501	0.00501	CcSEcCtD
Iohexol—Anaphylactic shock—Vemurafenib—skin cancer	0.00491	0.00491	CcSEcCtD
Iohexol—Nervous system disorder—Vemurafenib—skin cancer	0.00482	0.00482	CcSEcCtD
Iohexol—Skin disorder—Vemurafenib—skin cancer	0.00477	0.00477	CcSEcCtD
Iohexol—Nausea—Vismodegib—skin cancer	0.00472	0.00472	CcSEcCtD
Iohexol—Angioedema—Imiquimod—skin cancer	0.00469	0.00469	CcSEcCtD
Iohexol—Injection site reaction—Docetaxel—skin cancer	0.00465	0.00465	CcSEcCtD
Iohexol—Malaise—Imiquimod—skin cancer	0.00463	0.00463	CcSEcCtD
Iohexol—Syncope—Imiquimod—skin cancer	0.0046	0.0046	CcSEcCtD
Iohexol—Hypotension—Vemurafenib—skin cancer	0.00459	0.00459	CcSEcCtD
Iohexol—Loss of consciousness—Imiquimod—skin cancer	0.00451	0.00451	CcSEcCtD
Iohexol—Muscular weakness—Temozolomide—skin cancer	0.0045	0.0045	CcSEcCtD
Iohexol—Cough—Imiquimod—skin cancer	0.00448	0.00448	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00448	0.00448	CcSEcCtD
Iohexol—Cardiac arrest—Fluorouracil—skin cancer	0.00447	0.00447	CcSEcCtD
Iohexol—Convulsion—Imiquimod—skin cancer	0.00445	0.00445	CcSEcCtD
Iohexol—Hypertension—Imiquimod—skin cancer	0.00443	0.00443	CcSEcCtD
Iohexol—Arthralgia—Imiquimod—skin cancer	0.00437	0.00437	CcSEcCtD
Iohexol—Discomfort—Imiquimod—skin cancer	0.00432	0.00432	CcSEcCtD
Iohexol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00424	0.00424	CcSEcCtD
Iohexol—Lightheadedness—Docetaxel—skin cancer	0.00419	0.00419	CcSEcCtD
Iohexol—Pulmonary oedema—Docetaxel—skin cancer	0.00417	0.00417	CcSEcCtD
Iohexol—Muscular weakness—Fluorouracil—skin cancer	0.00415	0.00415	CcSEcCtD
Iohexol—Shock—Imiquimod—skin cancer	0.00412	0.00412	CcSEcCtD
Iohexol—Nervous system disorder—Imiquimod—skin cancer	0.00411	0.00411	CcSEcCtD
Iohexol—Skin disorder—Imiquimod—skin cancer	0.00407	0.00407	CcSEcCtD
Iohexol—Thrombophlebitis—Docetaxel—skin cancer	0.00392	0.00392	CcSEcCtD
Iohexol—Flushing—Bleomycin—skin cancer	0.00389	0.00389	CcSEcCtD
Iohexol—Body temperature increased—Vemurafenib—skin cancer	0.00388	0.00388	CcSEcCtD
Iohexol—Swelling—Docetaxel—skin cancer	0.00385	0.00385	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Iohexol—Paraesthesia—Imiquimod—skin cancer	0.00376	0.00376	CcSEcCtD
Iohexol—Dyspnoea—Imiquimod—skin cancer	0.00373	0.00373	CcSEcCtD
Iohexol—Somnolence—Imiquimod—skin cancer	0.00372	0.00372	CcSEcCtD
Iohexol—Erythema—Bleomycin—skin cancer	0.00365	0.00365	CcSEcCtD
Iohexol—Flushing—Dactinomycin—skin cancer	0.00363	0.00363	CcSEcCtD
Iohexol—Hypersensitivity—Vemurafenib—skin cancer	0.00362	0.00362	CcSEcCtD
Iohexol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00362	0.00362	CcSEcCtD
Iohexol—Pain—Imiquimod—skin cancer	0.00358	0.00358	CcSEcCtD
Iohexol—Urinary tract disorder—Temozolomide—skin cancer	0.00349	0.00349	CcSEcCtD
Iohexol—Pruritus—Vemurafenib—skin cancer	0.00348	0.00348	CcSEcCtD
Iohexol—Urethral disorder—Temozolomide—skin cancer	0.00346	0.00346	CcSEcCtD
Iohexol—Feeling abnormal—Imiquimod—skin cancer	0.00345	0.00345	CcSEcCtD
Iohexol—Gastrointestinal pain—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Iohexol—Erythema—Dactinomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Iohexol—Pain in extremity—Docetaxel—skin cancer	0.0034	0.0034	CcSEcCtD
Iohexol—Diarrhoea—Vemurafenib—skin cancer	0.00336	0.00336	CcSEcCtD
Iohexol—Urticaria—Imiquimod—skin cancer	0.00333	0.00333	CcSEcCtD
Iohexol—Abdominal pain—Imiquimod—skin cancer	0.00331	0.00331	CcSEcCtD
Iohexol—Body temperature increased—Imiquimod—skin cancer	0.00331	0.00331	CcSEcCtD
Iohexol—Eye disorder—Temozolomide—skin cancer	0.0033	0.0033	CcSEcCtD
Iohexol—Malaise—Bleomycin—skin cancer	0.00329	0.00329	CcSEcCtD
Iohexol—Flushing—Temozolomide—skin cancer	0.00328	0.00328	CcSEcCtD
Iohexol—Cardiac disorder—Temozolomide—skin cancer	0.00328	0.00328	CcSEcCtD
Iohexol—Dizziness—Vemurafenib—skin cancer	0.00325	0.00325	CcSEcCtD
Iohexol—Angiopathy—Temozolomide—skin cancer	0.00321	0.00321	CcSEcCtD
Iohexol—Immune system disorder—Temozolomide—skin cancer	0.00319	0.00319	CcSEcCtD
Iohexol—Mediastinal disorder—Temozolomide—skin cancer	0.00318	0.00318	CcSEcCtD
Iohexol—Cough—Bleomycin—skin cancer	0.00318	0.00318	CcSEcCtD
Iohexol—Vomiting—Vemurafenib—skin cancer	0.00312	0.00312	CcSEcCtD
Iohexol—Rash—Vemurafenib—skin cancer	0.0031	0.0031	CcSEcCtD
Iohexol—Mental disorder—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Iohexol—Dermatitis—Vemurafenib—skin cancer	0.00309	0.00309	CcSEcCtD
Iohexol—Hypersensitivity—Imiquimod—skin cancer	0.00309	0.00309	CcSEcCtD
Iohexol—Headache—Vemurafenib—skin cancer	0.00308	0.00308	CcSEcCtD
Iohexol—Erythema—Temozolomide—skin cancer	0.00308	0.00308	CcSEcCtD
Iohexol—Discomfort—Bleomycin—skin cancer	0.00307	0.00307	CcSEcCtD
Iohexol—Malaise—Dactinomycin—skin cancer	0.00307	0.00307	CcSEcCtD
Iohexol—Dysgeusia—Temozolomide—skin cancer	0.00301	0.00301	CcSEcCtD
Iohexol—Confusional state—Bleomycin—skin cancer	0.003	0.003	CcSEcCtD
Iohexol—Anaphylactic shock—Bleomycin—skin cancer	0.00298	0.00298	CcSEcCtD
Iohexol—Pruritus—Imiquimod—skin cancer	0.00296	0.00296	CcSEcCtD
Iohexol—Nausea—Vemurafenib—skin cancer	0.00292	0.00292	CcSEcCtD
Iohexol—Arrhythmia—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Iohexol—Bronchospasm—Docetaxel—skin cancer	0.00289	0.00289	CcSEcCtD
Iohexol—Tremor—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Iohexol—Diarrhoea—Imiquimod—skin cancer	0.00287	0.00287	CcSEcCtD
Iohexol—Discomfort—Dactinomycin—skin cancer	0.00286	0.00286	CcSEcCtD
Iohexol—Erythema—Fluorouracil—skin cancer	0.00283	0.00283	CcSEcCtD
Iohexol—Angioedema—Temozolomide—skin cancer	0.00281	0.00281	CcSEcCtD
Iohexol—Hypotension—Bleomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Iohexol—Malaise—Temozolomide—skin cancer	0.00277	0.00277	CcSEcCtD
Iohexol—Dizziness—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00271	0.00271	CcSEcCtD
Iohexol—Cough—Temozolomide—skin cancer	0.00268	0.00268	CcSEcCtD
Iohexol—Paraesthesia—Bleomycin—skin cancer	0.00267	0.00267	CcSEcCtD
Iohexol—Convulsion—Temozolomide—skin cancer	0.00267	0.00267	CcSEcCtD
Iohexol—Vomiting—Imiquimod—skin cancer	0.00266	0.00266	CcSEcCtD
Iohexol—Hypertension—Temozolomide—skin cancer	0.00266	0.00266	CcSEcCtD
Iohexol—Dyspnoea—Bleomycin—skin cancer	0.00265	0.00265	CcSEcCtD
Iohexol—Rash—Imiquimod—skin cancer	0.00264	0.00264	CcSEcCtD
Iohexol—Dermatitis—Imiquimod—skin cancer	0.00264	0.00264	CcSEcCtD
Iohexol—Headache—Imiquimod—skin cancer	0.00262	0.00262	CcSEcCtD
Iohexol—Arthralgia—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Iohexol—Discomfort—Temozolomide—skin cancer	0.00259	0.00259	CcSEcCtD
Iohexol—Renal failure—Docetaxel—skin cancer	0.00257	0.00257	CcSEcCtD
Iohexol—Pain—Bleomycin—skin cancer	0.00254	0.00254	CcSEcCtD
Iohexol—Confusional state—Temozolomide—skin cancer	0.00253	0.00253	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00253	0.00253	CcSEcCtD
Iohexol—Anaphylactic shock—Temozolomide—skin cancer	0.00251	0.00251	CcSEcCtD
Iohexol—Nausea—Imiquimod—skin cancer	0.00249	0.00249	CcSEcCtD
Iohexol—Nervous system disorder—Temozolomide—skin cancer	0.00246	0.00246	CcSEcCtD
Iohexol—Convulsion—Fluorouracil—skin cancer	0.00246	0.00246	CcSEcCtD
Iohexol—Feeling abnormal—Bleomycin—skin cancer	0.00245	0.00245	CcSEcCtD
Iohexol—Skin disorder—Temozolomide—skin cancer	0.00244	0.00244	CcSEcCtD
Iohexol—Discomfort—Fluorouracil—skin cancer	0.00238	0.00238	CcSEcCtD
Iohexol—Pain—Dactinomycin—skin cancer	0.00237	0.00237	CcSEcCtD
Iohexol—Urticaria—Bleomycin—skin cancer	0.00236	0.00236	CcSEcCtD
Iohexol—Body temperature increased—Bleomycin—skin cancer	0.00235	0.00235	CcSEcCtD
Iohexol—Confusional state—Fluorouracil—skin cancer	0.00233	0.00233	CcSEcCtD
Iohexol—Urinary tract disorder—Docetaxel—skin cancer	0.00232	0.00232	CcSEcCtD
Iohexol—Anaphylactic shock—Fluorouracil—skin cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Urethral disorder—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Iohexol—Feeling abnormal—Dactinomycin—skin cancer	0.00229	0.00229	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00229	0.00229	CcSEcCtD
Iohexol—Gastrointestinal pain—Dactinomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Nervous system disorder—Fluorouracil—skin cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Paraesthesia—Temozolomide—skin cancer	0.00225	0.00225	CcSEcCtD
Iohexol—Dyspnoea—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Iohexol—Somnolence—Temozolomide—skin cancer	0.00223	0.00223	CcSEcCtD
Iohexol—Eye disorder—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Iohexol—Abdominal pain—Dactinomycin—skin cancer	0.00219	0.00219	CcSEcCtD
Iohexol—Body temperature increased—Dactinomycin—skin cancer	0.00219	0.00219	CcSEcCtD
Iohexol—Hypersensitivity—Bleomycin—skin cancer	0.00219	0.00219	CcSEcCtD
Iohexol—Flushing—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Cardiac disorder—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Gastrointestinal disorder—Temozolomide—skin cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Hypotension—Fluorouracil—skin cancer	0.00216	0.00216	CcSEcCtD
Iohexol—Pain—Temozolomide—skin cancer	0.00215	0.00215	CcSEcCtD
Iohexol—Angiopathy—Docetaxel—skin cancer	0.00213	0.00213	CcSEcCtD
Iohexol—Immune system disorder—Docetaxel—skin cancer	0.00212	0.00212	CcSEcCtD
Iohexol—Mediastinal disorder—Docetaxel—skin cancer	0.00212	0.00212	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Pruritus—Bleomycin—skin cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Arrhythmia—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Iohexol—Paraesthesia—Fluorouracil—skin cancer	0.00208	0.00208	CcSEcCtD
Iohexol—Feeling abnormal—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Iohexol—Dyspnoea—Fluorouracil—skin cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Mental disorder—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Somnolence—Fluorouracil—skin cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Gastrointestinal pain—Temozolomide—skin cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Erythema—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Hypersensitivity—Dactinomycin—skin cancer	0.00204	0.00204	CcSEcCtD
Iohexol—Dysgeusia—Docetaxel—skin cancer	0.002	0.002	CcSEcCtD
Iohexol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.002	0.002	CcSEcCtD
Iohexol—Urticaria—Temozolomide—skin cancer	0.00199	0.00199	CcSEcCtD
Iohexol—Body temperature increased—Temozolomide—skin cancer	0.00198	0.00198	CcSEcCtD
Iohexol—Abdominal pain—Temozolomide—skin cancer	0.00198	0.00198	CcSEcCtD
Iohexol—Pain—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Iohexol—Muscle spasms—Docetaxel—skin cancer	0.00197	0.00197	CcSEcCtD
Iohexol—Feeling abnormal—Fluorouracil—skin cancer	0.00191	0.00191	CcSEcCtD
Iohexol—Diarrhoea—Dactinomycin—skin cancer	0.0019	0.0019	CcSEcCtD
Iohexol—Vomiting—Bleomycin—skin cancer	0.00189	0.00189	CcSEcCtD
Iohexol—Rash—Bleomycin—skin cancer	0.00188	0.00188	CcSEcCtD
Iohexol—Dermatitis—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Iohexol—Hypersensitivity—Temozolomide—skin cancer	0.00185	0.00185	CcSEcCtD
Iohexol—Urticaria—Fluorouracil—skin cancer	0.00184	0.00184	CcSEcCtD
Iohexol—Syncope—Docetaxel—skin cancer	0.00183	0.00183	CcSEcCtD
Iohexol—Body temperature increased—Fluorouracil—skin cancer	0.00183	0.00183	CcSEcCtD
Iohexol—Loss of consciousness—Docetaxel—skin cancer	0.0018	0.0018	CcSEcCtD
Iohexol—Cough—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Pruritus—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Convulsion—Docetaxel—skin cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Nausea—Bleomycin—skin cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Hypertension—Docetaxel—skin cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Vomiting—Dactinomycin—skin cancer	0.00176	0.00176	CcSEcCtD
Iohexol—Rash—Dactinomycin—skin cancer	0.00175	0.00175	CcSEcCtD
Iohexol—Arthralgia—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Iohexol—Diarrhoea—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Iohexol—Hypersensitivity—Fluorouracil—skin cancer	0.0017	0.0017	CcSEcCtD
Iohexol—Confusional state—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Iohexol—Anaphylactic shock—Docetaxel—skin cancer	0.00167	0.00167	CcSEcCtD
Iohexol—Dizziness—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Iohexol—Nausea—Dactinomycin—skin cancer	0.00165	0.00165	CcSEcCtD
Iohexol—Shock—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Nervous system disorder—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Pruritus—Fluorouracil—skin cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Skin disorder—Docetaxel—skin cancer	0.00162	0.00162	CcSEcCtD
Iohexol—Vomiting—Temozolomide—skin cancer	0.0016	0.0016	CcSEcCtD
Iohexol—Rash—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Iohexol—Diarrhoea—Fluorouracil—skin cancer	0.00158	0.00158	CcSEcCtD
Iohexol—Dermatitis—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Iohexol—Headache—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Iohexol—Hypotension—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Iohexol—Dizziness—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Iohexol—Paraesthesia—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Iohexol—Nausea—Temozolomide—skin cancer	0.00149	0.00149	CcSEcCtD
Iohexol—Dyspnoea—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Iohexol—Somnolence—Docetaxel—skin cancer	0.00148	0.00148	CcSEcCtD
Iohexol—Vomiting—Fluorouracil—skin cancer	0.00147	0.00147	CcSEcCtD
Iohexol—Rash—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Dermatitis—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Headache—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Iohexol—Gastrointestinal disorder—Docetaxel—skin cancer	0.00144	0.00144	CcSEcCtD
Iohexol—Pain—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Iohexol—Feeling abnormal—Docetaxel—skin cancer	0.00138	0.00138	CcSEcCtD
Iohexol—Nausea—Fluorouracil—skin cancer	0.00137	0.00137	CcSEcCtD
Iohexol—Gastrointestinal pain—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Iohexol—Abdominal pain—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Body temperature increased—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Hypersensitivity—Docetaxel—skin cancer	0.00123	0.00123	CcSEcCtD
Iohexol—Pruritus—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Iohexol—Diarrhoea—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Iohexol—Dizziness—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Iohexol—Vomiting—Docetaxel—skin cancer	0.00106	0.00106	CcSEcCtD
Iohexol—Rash—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Iohexol—Dermatitis—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Iohexol—Headache—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Iohexol—Nausea—Docetaxel—skin cancer	0.000992	0.000992	CcSEcCtD
